Targeting PIK3CA-mutant advanced breast cancer in the clinical setting.
View/ Open
Date
2017-07-01ICR Author
Author
Chopra, N
Turner, NC
Type
Journal Article
Metadata
Show full item recordCollections
Subject
Humans
Breast Neoplasms
Mutation
Phosphatidylinositol 3-Kinases
Class I Phosphatidylinositol 3-Kinases
Research team
Molecular Oncology
Language
eng
Date accepted
2017-05-11
License start date
2017-07
Citation
The Lancet. Oncology, 2017, 18 (7), pp. 842 - 843
Publisher
ELSEVIER SCIENCE INC